Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00529 Zileuton Products (Zyflo/zileuton ER)PayerPolicy · BCBSLA-00529-B45D14655E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00546 Zurampic, Duzallo (lesinurad Products) - Retired PolicyPayerPolicy · BCBSLA-00546-B859604F3D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00191 zoledronic acid (Zometa, Reclast)-Retired policyPayerPolicy · BCBSLA-00191-C5394700C5 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00137 Wireless Capsule Endoscopy for Gastrointestinal (GI) DisordersPayerPolicy · BCBSLA-00137-B47CBB4C69 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00022 Whole Gland Cryoablation of Prostate Cancer-Retired PolicyPayerPolicy · BCBSLA-00022-7C1A61E5DA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00389 Rapid Whole Genome Sequencing for Diagnosis of Genetic DisordersPayerPolicy · BCBSLA-00389-9CE04210E1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00280 Viscocanalostomy and CanaloplastyPayerPolicy · BCBSLA-00280-663E548296 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00136 Virtual Colonoscopy/CT Colonography-Retired PolicyPayerPolicy · BCBSLA-00136-9CCCC6D9DB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00244 Vigabatrin ProductsPayerPolicy · BCBSLA-00244-958F8BC207 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00556 Vestibular Function TestingPayerPolicy · BCBSLA-00556-019F4D1336 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00163 Vertebral Fracture Assessment with Bone Densitometry - Retired PolicyPayerPolicy · BCBSLA-00163-0D27196235 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00135 Vertebral Axial DecompressionPayerPolicy · BCBSLA-00135-9E2C73220F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00439 vedolizumab (Entyvio)PayerPolicy · BCBSLA-00439-C149E4E3B7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00442 Multibiomarker Disease Activity Blood Test for Rheumatoid Arthritis - Retired PolicyPayerPolicy · BCBSLA-00442-D806C1CA79 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00134 Vagus Nerve StimulationPayerPolicy · BCBSLA-00134-1E1F894DBE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00133 Vacuum Therapy as a Treatment for Female Sexual Dysfunction - Retired PolicyPayerPolicy · BCBSLA-00133-8BC0CCD866 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00132 Vacuum-Assisted Closure of Chronic Wounds (Negative Pressure Wound Therapy)PayerPolicy · BCBSLA-00132-30B3C7A7B8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00242 ustekinumab ProductsPayerPolicy · BCBSLA-00242-1E0C13813D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00268 Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer- Retired PolicyPayerPolicy · BCBSLA-00268-5A0D476AC0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00129 Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance - Retired PolicyPayerPolicy · BCBSLA-00129-122E1900D1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00483 Urinary Metabolite Tests for Adherence to Direct-Acting Antiviral Medications for Hepatitis C-Retired PolicyPayerPolicy · BCBSLA-00483-8617BCD52A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00387 Drug Testing in Pain Management and Substance Use Disorder TreatmentPayerPolicy · BCBSLA-00387-5BB455413F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00507 uridine triacetate (Xuriden)PayerPolicy · BCBSLA-00507-7111A36419 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00128 T-Wave Alternans- Retired PolicyPayerPolicy · BCBSLA-00128-FD6277D3F9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00391 Tumor Treating Fields TherapyPayerPolicy · BCBSLA-00391-358DAC67AC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00557 Select Drugs for ConstipationPayerPolicy · BCBSLA-00557-10BBA0749E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00034 Treatment of Varicose Veins/Venous InsufficiencyPayerPolicy · BCBSLA-00034-DE1A80FCD5 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00127 Treatment of TinnitusPayerPolicy · BCBSLA-00127-2A845A1125 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00209 Treatment of IGF-1 DeficiencyPayerPolicy · BCBSLA-00209-4AB546ACCC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00172 Treatment of HyperhidrosisPayerPolicy · BCBSLA-00172-389275BB61 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00373 Treatment of Hepatitis C with Triple Therapy (Ribavirin Plus Pegylated Interferon Alfa Plus telaprevir [Incivek] or boceprevir [Victrelis])-Retired Medical PolicyPayerPolicy · BCBSLA-00373-01DD7239A6 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00514 Treatment of Hepatitis C with sofosbuvir/velpatasvir (Epclusa, Authorized Generic)PayerPolicy · BCBSLA-00514-0CFBC23811 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00455 Treatment of Hepatitis C with sofosbuvir/ledipasvir (Harvoni, Authorized Generic)PayerPolicy · BCBSLA-00455-4590534B28 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00457 Treatment of Hepatitis C with simeprevir (Olysio) PLUS sofosbuvir (Sovaldi)-Retired PolicyPayerPolicy · BCBSLA-00457-D973D266F9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00462 Treatment of Hepatitis C with ombitasvir, paritaprevir, ritonavir, and dasabuvir (Viekira Pak)-Retired PolicyPayerPolicy · BCBSLA-00462-2161B76BED | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00478 Treatment of Hepatitis C with ombitasvir, paritaprevir, and ritonavir (Technivie)--Retired PolicyPayerPolicy · BCBSLA-00478-29E4A4E333 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00509 Treatment of Hepatitis C with elbasvir and grazoprevir (Zepatier)PayerPolicy · BCBSLA-00509-DC8A112080 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00374 Treatment of Hepatitis C with Dual Therapy (Ribavirin Plus Pegylated Interferon Alfa)PayerPolicy · BCBSLA-00374-AB4B780DA6 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00479 Treatment of Hepatitis C with daclatasvir (Daklinza) plus sofosbuvir (Sovaldi)--Retired PolicyPayerPolicy · BCBSLA-00479-1998CEA596 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00397 Treatment of Hepatitis C with a sofosbuvir (Sovaldi) Based RegimenPayerPolicy · BCBSLA-00397-1DE0C5BEF9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00396 Treatment of Hepatitis C with a simeprevir (Olysio) Based Regimen-Retired PolicyPayerPolicy · BCBSLA-00396-DBD6C14D68 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00171 Treatment of Hepatitis C and B with Pegylated Interferon and/or Ribavirin- Replaced PolicyPayerPolicy · BCBSLA-00171-68DAFB5B9B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00254 Transvaginal and Transurethral Radiofrequency Tissue Remodeling for Urinary Stress Incontinence--Retired PolicyPayerPolicy · BCBSLA-00254-8B0BE8BC4A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00505 Transtympanic Micropressure Applications as a Treatment of Meniere Disease-Retired PolicyPayerPolicy · BCBSLA-00505-CB2F29E12E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00125 Transpupillary Thermotherapy for Treatment of Choroidal Neovascular Conditions- Retired PolicyPayerPolicy · BCBSLA-00125-48E7258CD8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00124 Transjugular Intrahepatic Portosystemic Shunt (TIPS) - Retired PolicyPayerPolicy · BCBSLA-00124-1939E0F342 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00123 Transesophageal Endoscopic Therapies for Gastroesophageal Reflux DiseasePayerPolicy · BCBSLA-00123-0048D2421B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00121 Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic DisordersPayerPolicy · BCBSLA-00121-8ADA1A4961 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00120 Transcoronary Ablation of Septal Hypertrophy (TASH) - Retired PolicyPayerPolicy · BCBSLA-00120-E222C4E1CE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00183 Transciliary Fistulization for the Treatment of Glaucoma - Retired PolicyPayerPolicy · BCBSLA-00183-2CE051040E | New policy |
|---|